Literature DB >> 4602874

Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.

T Godal, B Myrvang, D R Samuel, W F Ross, M Lofgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4602874

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand Suppl


× No keyword cloud information.
  18 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy.

Authors:  N Bahia El Idrissi; S Hakobyan; V Ramaglia; A Geluk; B Paul Morgan; P Kumar Das; F Baas
Journal:  Clin Exp Immunol       Date:  2016-03-31       Impact factor: 4.330

3.  In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin.

Authors:  G Bjune
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Immunofluorescence studies in reactional leprosy with relevance to treatment.

Authors:  W R Faber; D L Leiker; R H Cormane
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

5.  Histological classification and the immunological spectrum of leprosy.

Authors:  D S Ridley
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

6.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

7.  Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.

Authors:  G Bjune; R S Barnetson
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

9.  Tumor necrosis factor production in patients with leprosy.

Authors:  P F Barnes; D Chatterjee; P J Brennan; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Authors:  Dennis Montoya; Daniel Cruz; Rosane M B Teles; Delphine J Lee; Maria Teresa Ochoa; Stephan R Krutzik; Rene Chun; Mirjam Schenk; Xiaoran Zhang; Benjamin G Ferguson; Anne E Burdick; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Genhong Cheng; Robert L Modlin
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.